Literature DB >> 11290380

An in vitro model for the study of microglia-induced neurodegeneration: involvement of nitric oxide and tumor necrosis factor-alpha.

K Hemmer1, L Fransen, H Vanderstichele, E Vanmechelen, P Heuschling.   

Abstract

The precise function of activated microglia and their secretory products remains controversial. In order to assess the role of microglial secretion products, we established an in vitro model of an inflammatory reaction in the brain by co-culturing microglial and neuronal cell lines. Upon stimulation with interferon-gamma and lipopolysaccharides, the microglial cells adopted an activated phenotype and secreted tumor necrosis factor-alpha (TNF-alpha), prostaglandin E(2) and nitric oxide (NO). Neuronal degeneration was quantified by measuring the concentrations of microtubule associated protein tau and neuron specific enolase, which are also used as diagnostic tool in Alzheimer's disease, in supernatants. In activated contact co-cultures, the levels of these neuronal markers were significantly raised compared to non-activated co-cultures. NO-synthase inhibitors significantly diminished the rise of tau in activated co-cultures, while indomethacin, superoxide dismutase, or a neutralizing TNF-alpha antibody did not. When a chemical NO-donor or TNF-alpha were added to pure neuronal cultures, cell viability was significantly reduced. TNF-alpha increased neuronal sensitivity towards NO. There were indications that a part of the cells died by apoptosis. This model demonstrates a neurotoxic role for NO in microglia-induced neurodegeneration and provides a valuable in vitro tool for the study of microglia-neuron interactions during inflammation in the brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290380     DOI: 10.1016/s0197-0186(00)00119-4

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  18 in total

Review 1.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

2.  CNS inflammation and neurodegeneration.

Authors:  Tanuja Chitnis; Howard L Weiner
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

3.  Walnut-Associated Fatty Acids Inhibit LPS-Induced Activation of BV-2 Microglia.

Authors:  Amanda N Carey; Derek R Fisher; Donna F Bielinski; Danielle S Cahoon; Barbara Shukitt-Hale
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

4.  Trans-Cinnamaldehyde, An Essential Oil in Cinnamon Powder, Ameliorates Cerebral Ischemia-Induced Brain Injury via Inhibition of Neuroinflammation Through Attenuation of iNOS, COX-2 Expression and NFκ-B Signaling Pathway.

Authors:  Yuh-Fung Chen; Yu-Wen Wang; Wei-Shih Huang; Ming-Ming Lee; W Gibson Wood; Yuk-Man Leung; Huei-Yann Tsai
Journal:  Neuromolecular Med       Date:  2016-04-18       Impact factor: 3.843

Review 5.  Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies.

Authors:  Brigitte Onténiente; Sowmyalakshmí Rasika; Alexandra Benchoua; Christelle Guégan
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

Review 6.  Inflammation as a causative factor in the aetiology of Parkinson's disease.

Authors:  P S Whitton
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

Review 7.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease.

Authors:  Isaac G Onyango
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

Review 8.  Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

Authors:  Malú G Tansey; Matthew S Goldberg
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

9.  Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.

Authors:  Lalida Rojanathammanee; Eric J Murphy; Colin K Combs
Journal:  J Neuroinflammation       Date:  2011-05-09       Impact factor: 8.322

10.  A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function.

Authors:  Siranush A Sargsyan; Daniel J Blackburn; Siân C Barber; Julian Grosskreutz; Kurt J De Vos; Peter N Monk; Pamela J Shaw
Journal:  BMC Neurosci       Date:  2011-09-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.